We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Public Health

Public Health

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Beyond the Lead Apron: New Evidence of High Orthopedic and Reproductive Risks in Cardiac Electrophysiology
CardiologyElectrophysiologyoccupational health

Beyond the Lead Apron: New Evidence of High Orthopedic and Reproductive Risks in Cardiac Electrophysiology

By MedXY|Dec 25, 2025

A global Heart Rhythm Society survey reveals that 41% of EP professionals suffer from orthopedic injuries and 50% of women face pregnancy complications, highlighting the urgent need for systemic improvements in laboratory ergonomics and rad

Beyond Patient Factors: Modifying Surgical Practice to Mitigate Racial Disparities in Benign Hysterectomy
newsChất lượng phẫu thuậthealth equity

Beyond Patient Factors: Modifying Surgical Practice to Mitigate Racial Disparities in Benign Hysterectomy

By MedXY|Dec 24, 2025

This study identifies key modifiable surgical and hospital-level factors—including surgical approach and antibiotic adherence—that contribute to the disproportionately higher rate of postoperative complications experienced by Black patients

Efficacy of mHealth Interventions for Smoking Cessation in Tuberculosis Patients: Insights from a Cluster Randomized Clinical Trial
AIclinical trialmHealth

Efficacy of mHealth Interventions for Smoking Cessation in Tuberculosis Patients: Insights from a Cluster Randomized Clinical Trial

By MedXY|Dec 24, 2025

An mHealth text messaging intervention significantly improves smoking cessation rates and reduces mortality among TB patients compared to usual care, supporting its implementation in TB programs.

FDA Modernization Act 3.0: A Legislative Catalyst for the Post-Animal Testing Era in Clinical Pharmacology
newsDrug Development

FDA Modernization Act 3.0: A Legislative Catalyst for the Post-Animal Testing Era in Clinical Pharmacology

By MedXY|Dec 23, 2025

The U.S. Senate’s unanimous passage of the FDA Modernization Act 3.0 marks a definitive shift in drug regulation, formally replacing ‘animal’ mandates with ‘nonclinical’ methodologies like organ-on-a-chip and A

Occupation Matters: New Data Reveal Wide Disparities in US Cancer Mortality Among Working-Age Adults
newshealth equityoccupational health

Occupation Matters: New Data Reveal Wide Disparities in US Cancer Mortality Among Working-Age Adults

By MedXY|Dec 23, 2025

A comprehensive population study of 450,453 deaths identifies specific occupations, including fishing, mining, and funeral services, with disproportionately high cancer mortality, suggesting a complex interplay of workplace exposures and st

Benchmarking Global Progress in Non-Communicable Diseases: A Comprehensive Analysis of Cause-Specific Mortality Trends from 2001 to 2019
Clinical Updatesepidemiologyglobal health

Benchmarking Global Progress in Non-Communicable Diseases: A Comprehensive Analysis of Cause-Specific Mortality Trends from 2001 to 2019

By MedXY|Dec 23, 2025

From 2010 to 2019, NCD mortality declined in 80% of countries worldwide, driven primarily by reductions in circulatory diseases, with notable regional and cause-specific heterogeneity and slower progress than the previous decade.

Individualized Feedback Letters Fail to Reduce Long-Term Alcohol Consumption: Insights from a 4-Year RCT
newsdigital healthpublic health

Individualized Feedback Letters Fail to Reduce Long-Term Alcohol Consumption: Insights from a 4-Year RCT

By MedXY|Dec 23, 2025

A 4-year randomized controlled trial found that computer-generated feedback letters failed to reduce alcohol consumption in the general population. Unexpectedly, the control group showed greater reduction at 48 months, suggesting that curre

Optimizing Opioid Use Disorder Treatment: When Does 300 mg Outperform 100 mg of Extended-Release Buprenorphine?
newsbuprenorphinefentanyl

Optimizing Opioid Use Disorder Treatment: When Does 300 mg Outperform 100 mg of Extended-Release Buprenorphine?

By MedXY|Dec 21, 2025

This randomized clinical trial compares 100-mg and 300-mg maintenance doses of extended-release buprenorphine. While overall efficacy was similar, the 300-mg dose significantly improved abstinence among patients with high-frequency fentanyl

Beyond the Common Cold: Deciphering the Surge of Influenza Subclade K Across Europe
Infectious Diseasesinfluenzapublic health

Beyond the Common Cold: Deciphering the Surge of Influenza Subclade K Across Europe

By MedXY|Dec 20, 2025

A new influenza strain, Subclade K (AH3N2 J.2.4.1), is dominating Europe’s flu season with a 90% prevalence rate. Experts emphasize that while the strain is highly transmissible, vaccination remains the most effective tool for prevent

High-Dose Extended-Release Buprenorphine: A Targeted Strategy for the Fentanyl-Driven Opioid Crisis
newsbuprenorphinefentanyl

High-Dose Extended-Release Buprenorphine: A Targeted Strategy for the Fentanyl-Driven Opioid Crisis

By MedXY|Dec 20, 2025

This randomized clinical trial compares 100-mg versus 300-mg maintenance doses of extended-release buprenorphine. While overall efficacy was similar, the 300-mg dose significantly improved abstinence rates among heavy fentanyl users, offeri

Academic vs. Industry: Why Non-Industry Trials Are Failing to Reach the Finish Line
Internal Medicineclinical trialsEvidence-Based Medicine

Academic vs. Industry: Why Non-Industry Trials Are Failing to Reach the Finish Line

By MedXY|Dec 20, 2025

A systematic review of 347 randomized trials reveals that non-industry-sponsored trials lag significantly behind industry counterparts in registration and results publication, with nearly one-third of all trials discontinued prematurely due

Why Our Strength and Fitness Peak in Our 20s–30s — and How Exercise Can Push Back the Clock
Internal Medicineagingexercise

Why Our Strength and Fitness Peak in Our 20s–30s — and How Exercise Can Push Back the Clock

By MedXY|Dec 20, 2025

A 47-year study shows physical capacity peaks in the late 20s–30s and accelerates downward from about age 40 — but regular exercise, started at any age, can meaningfully delay decline.

High-Dose Influenza Vaccine Fails to Significantly Reduce Combined Influenza and Pneumonia Hospitalizations: Insights from the DANFLU-2 Trial
Infectious Diseasesgeriatricshospitalization

High-Dose Influenza Vaccine Fails to Significantly Reduce Combined Influenza and Pneumonia Hospitalizations: Insights from the DANFLU-2 Trial

By MedXY|Dec 18, 2025

The DANFLU-2 trial found that while high-dose influenza vaccines significantly reduced influenza-specific hospitalizations in older adults, they did not reach statistical significance for the combined primary endpoint of influenza or pneumo

Electronic Cigarettes for Smoking Cessation: An Updated Review
newseffectivenesselectronic cigarettes

Electronic Cigarettes for Smoking Cessation: An Updated Review

By MedXY|Dec 18, 2025

This review examines the safety and effectiveness of electronic cigarettes as aids to quit smoking, showing increased abstinence rates compared to traditional therapies and no significant serious adverse events reported.

Nicotine E-Cigarettes Show Higher Quit Rates Than Traditional Nicotine Replacement Therapy
newselectronic cigarettesnicotine replacement therapy

Nicotine E-Cigarettes Show Higher Quit Rates Than Traditional Nicotine Replacement Therapy

By MedXY|Dec 17, 2025

Updated Cochrane review finds nicotine e-cigarettes increase smoking cessation success compared to NRT and non-nicotine e-cigarettes, with no clear difference in serious adverse events.

HPV Vaccination Significantly Reduces Precancerous Lesions and Anogenital Warts: Evidence from a Network Meta‑Analysis
Infectious Diseasesprecancerous lesions

HPV Vaccination Significantly Reduces Precancerous Lesions and Anogenital Warts: Evidence from a Network Meta‑Analysis

By MedXY|Dec 17, 2025

A large network meta‑analysis confirms HPV vaccines effectively reduce CIN2+ and anogenital warts, with no major safety concerns.

Most Very Preterm Infants Require Hospital Readmission Before Age 2 — Neonatal Morbidities Strongly Increase Days Spent in Hospital
newsneonatal morbidityrehospitalization

Most Very Preterm Infants Require Hospital Readmission Before Age 2 — Neonatal Morbidities Strongly Increase Days Spent in Hospital

By MedXY|Dec 15, 2025

A national cohort study from England and Wales found two-thirds of infants born <32 weeks’ gestation had ≥1 hospital admission before age 2, with lower gestational age and neonatal morbidities (BPD, severe NEC, brain injury) substantiall

Enhancing Access to Mifepristone via Community Pharmacies: Evidence from Routine Prescription Regulation in British Columbia, Canada
Clinical Updateshealthcare disparities

Enhancing Access to Mifepristone via Community Pharmacies: Evidence from Routine Prescription Regulation in British Columbia, Canada

By MedXY|Dec 15, 2025

This review synthesizes data on mifepristone availability at community pharmacies in BC, highlighting geographic coverage, dispensing gaps, and disparities influencing timely access to medication abortion.

Early-Life Famine Exposure in Chinese Immigrants Strongly Linked to Later Diabetes and Hypertension — But Not Cardiovascular Hospitalization
Diabetes & EndocrinologyHypertensiontype 2 diabetes

Early-Life Famine Exposure in Chinese Immigrants Strongly Linked to Later Diabetes and Hypertension — But Not Cardiovascular Hospitalization

By MedXY|Dec 14, 2025

A large Ontario cohort study links early-life exposure to the Great Chinese Famine with higher adult risks of type 2 diabetes and hypertension among Chinese immigrants, while cardiovascular hospitalization was not increased; methodological

Voucher for Healthy Foods and Diabetes Control: A Randomized Clinical Trial
Diabetes & Endocrinologyclinical trialdiabetes

Voucher for Healthy Foods and Diabetes Control: A Randomized Clinical Trial

By MedXY|Dec 13, 2025

This clinical trial evaluated monthly grocery vouchers for improving diabetes control in food-insecure patients, finding increased self-reported fruit and vegetable intake but no significant HbA1c improvement.

Prev
18 / 25
1…1617181920…25
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure

Browse by specialty

Open language-specific specialty feeds and department pages.

news6829 articlesCardiology1403 articlesClinical Updates1315 articlesOncology1176 articlesDiabetes & Endocrinology868 articlesNeurology834 articlesPublic Health605 articlesGastroenterology586 articles
Hematology-Oncology
513 articles
Pediatrics493 articles
Internal Medicine464 articles